Literature DB >> 3789756

[Restoration of depressed immune responses by PSK in C3H/He mice bearing the syngeneic X5563 tumor].

K Matsunaga, I Morita, Y Oguchi, T Fujii, C Yoshikumi, K Nomoto.   

Abstract

PSK is a protein-bound polysaccharide prepared from cultured mycelium of Coriolus versicolor. The effects of PSK on immunologic responsiveness were investigated in C3H/He mice bearing syngeneic X5563 tumor. The results were as follows. elayed foot pad reaction and antibody-forming capacity to sheep erythrocytes were depressed in tumor bearing mice, and such depression was prevented by oral or intraperitoneal administration of PSK. In vitro cytotoxic activity of splenic lymphocytes against the tumor was augmented by PSK administration. Antitumor effect was augmented by combination of PSK and X-irradiation. Delayed foot pad reaction to sheep erythrocytes was suppressed in normal C3H/He mice given immunosuppressive substance obtained from tumor-bearing mice, and the depressed reaction recovered to the normal level following PSK administration. These results show that PSK is effective in the syngeneic murine tumor system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789756

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

Review 1.  The promise of mRNA vaccines: a biotech and industrial perspective.

Authors:  Nicholas A C Jackson; Kent E Kester; Danilo Casimiro; Sanjay Gurunathan; Frank DeRosa
Journal:  NPJ Vaccines       Date:  2020-02-04       Impact factor: 7.344

2.  Postoperative adjuvant immunochemotherapy with mitomycin C, tegafur, PSK and/or OK-432 for gastric cancer, with special reference to the change in stimulation index after gastrectomy.

Authors:  T Hattori; T Nakajima; H Nakazato; T Tanabe; K Kikuchi; O Abe; T Kondo; T Taguchi; N Komi; K Sugimachi
Journal:  Jpn J Surg       Date:  1990-03

Review 3.  Trametes versicolor (Synn. Coriolus versicolor) Polysaccharides in Cancer Therapy: Targets and Efficacy.

Authors:  Solomon Habtemariam
Journal:  Biomedicines       Date:  2020-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.